key: cord-0811967-7fae4j37
authors: Post, Adrian; den Deurwaarder, Edwin S.G.; Bakker, Stephan J.L.; de Haas, Robbert J.; van Meurs, Matijs; Gansevoort, Ron T.; Berger, Stefan P.
title: Kidney Infarction in Patients With COVID-19
date: 2020-05-29
journal: Am J Kidney Dis
DOI: 10.1053/j.ajkd.2020.05.004
sha: 0ad6b762cab90e47acf853d6520343307a33ec50
doc_id: 811967
cord_uid: 7fae4j37

Coronavirus disease 2019 (COVID-19) is a contagious, life-threatening infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recent findings indicate an increased risk of acute kidney injury during COVID-19. The pathophysiological mechanisms leading to acute kidney injury in COVID-19 are unclear, but may include direct cytopathic effects of the virus on kidney tubular and endothelial cells, indirect damage caused by virus-induced cytokine release, and kidney hypoperfusion due to a restrictive fluid strategy. In this case-report we propose an additional pathophysiological mechanism. We describe two cases in which patients with COVID-19 developed a decrease in kidney function due to kidney infarction. These patients did not have atrial fibrillation. One of these patients was treated with therapeutic doses of low molecular weight heparin, whereafter no further deterioration of kidney function was observed. Our findings implicate that the differential diagnosis of acute kidney injury in COVID-19 patients should include kidney infarction, which may have important preventive and therapeutic implications.

Although diffuse alveolar damage and acute respiratory failure are the main features of COVID-19 infection, recent findings indicate an increased risk of acute kidney injury during the course of COVID-19 [1] [2] [3] . The pathophysiological mechanisms leading to acute kidney injury in COVID-19 are yet not fully elucidated, but may include direct cytopathic effects of the virus on kidney tubular and endothelial cells, indirect damage caused by virus-induced cytokine release or kidney hypoperfusion due to a restrictive fluid strategy [4] [5] [6] . In this casereport we propose an additional pathophysiological mechanism. We describe two cases of patients with COVID-19 that developed a decrease in kidney function due to kidney infarction.

A 62-year old man with a history of hypertension, Henoch-Schönlein glomerulonephritis (not biopsy proven) and a living-related kidney transplantation in 2016, presented with dry cough, fever, and worsening dyspnea during the last week. Maintenance immunosuppressive therapy consisted of mycophenolate mofetil 500 mg orally twice daily, tacrolimus (Advagraf 2 mg orally once daily) and prednisolone 5 mg orally once daily. His other medication consisted of metoprolol, losartan, barnidipine, hydrochlorothiazide, omeprazole and vitamin D. He did not take any anticoagulants. COVID-19 was diagnosed on March 26, 2020, based on a RT-PCR test that detected SARS-CoV-2 in a throat swab sample.

At presentation at the Queen Beatrix Hospital (Winterswijk, The Netherlands) the patient was tachypneic (respiratory rate 40/min) with an oxygen saturation of 89 %. His body temperature was 38.3 °C and the blood pressure was 121/73 mm Hg with a pulse rate of 59 beats per minute. There were no symptoms of emboli to the extremities. Laboratory findings were: Creactive protein (CRP) 7.0 mg/dL, leucocytes 5.4 *10 3 /μL, lymphocytes 0.8 * 10 3 /μL, serum LDH 290 U/L and serum creatinine 1.28 mg/dL. A chest X-ray showed bilateral

consolidations. An overview of demographic, clinical and laboratory findings is shown in Table 1 . Initial treatment was supportive with high flow oxygen therapy and tapering of immunosuppression. Thrombosis prophylaxis with dalteparin (2500 units daily) was prescribed.

On the ninth day after admission, the condition of the patient worsened. He became more tachypneic, his temperature rose to 38.6 °C. There were no episodes of hemodynamic instability and he did not experience abdominal pain, flank pain, nausea, vomiting, or worsening of previous arterial hypertension. He developed non-oliguric deterioration of kidney function, with a serum creatinine increase to 1.92 mg/dL and an LDH increase to 1145 U/L. CRP and leucocytes increased to 11.9 mg/dL and 19.9 * 10 3 /μL, respectively. Urinalysis demonstrated erythrocytes, and urinary sodium, creatinine and protein concentrations were 60 mEq/L, 45 mg/dL, and 37 mg/dL, respectively. The fractional excretion of sodium was 1.9%.

A CT-scan which was performed to rule out pulmonary embolism showed extensive consolidations and ground glass opacities on the pulmonary level, but no pulmonary emboli.

An unexpected finding were multiple wedge-shaped perfusion defects in the kidney allograft In the following period his condition slowly improved and at 20 days after admission, the patient was discharged. The mycophenolate was still on hold. At the time of discharge, serum LDH and serum creatinine had gradually decreased to levels of 560 U/L and 1.79 mg/dL, respectively.

A 58-year old male with a history of obstructive sleep apnea presented to the emergency ward with a two-week history of fever, cough, rhinorrhea, abdominal pain and increasing dyspnea. At presentation, the patient was tachypneic with an oxygen saturation of 90% with a non-rebreather mask with an oxygen flow rate of 15 liters per minute. His body temperature was 38.3 °C, blood pressure was 137/78 mm Hg with a pulse rate of 83 beats per minute. Laboratory findings were: CRP 33.4 mg/dL, leucocytes 17.9 * 10 3 /μL , lymphocytes 1.6 * 10 3 /μL, serum LDH 686 U/L and serum creatinine 0.89 mg/dL. A chest X-ray showed diffuse bilateral infiltrates.

He was admitted to intensive care of the University Medical Center Groningen (Groningen, the Netherlands) and was intubated the same day. A RT-PCR for SARS-CoV-2 was positive on a nasopharyngeal swab. Thrombosis prophylaxis with nadroparin was started (5700 units once daily). After two days he developed oliguria and deterioration of kidney function, with serum creatinine increasing from to 0.89 to 2.45 mg/dL, which increased to 7.99 mg/dL over the next two days. His serum LDH increased to 733 U/L. No sediment analysis was performed. Urinary sodium, creatinine and albumin concentration were 46 mEq/L, 111 mg/dL and 102 mg/dL, respectively. The fractional excretion of sodium was 1.5%. He did not have episodes of hemodynamic instability, new-onset hypertension, or atrial fibrillation in the period prior to acute kidney injury, but did develop cold feet and hands, with mottled skin and dry necrosis of three toes. Four days after admission anuria led to the initiation of continuous veno-venous hemofiltration. This treatment was complicated by frequent filter failure due to clotting necessitating the addition of systemic heparinization next to regular regional citrate anticoagulation targeting a therapeutic aPTT. At day ten after admission the patient developed a bloated abdomen with absence of bowel sounds. A CT-scan suggested bowel ischemia and revealed multiple wedge-shaped kidney infarctions, demonstrated in Figure 1C -D. One meter of small bowel with transmural ischemia was resected. Anti-cardiolipin and beta-2-glycoprotein 1 antibody levels were within normal limits. Anticoagulation was continued with nadroparin at a therapeutic dose with anti-factor Xa monitoring. In the following days, the patient showed gradual respiratory improvement and increasing diuresis. At day 28 after admission kidney replacement therapy was stopped, whereas the patient was still dependent on mechanical ventilation. At 45 days after admission the patient could be extubated. At 47 days after admission, he was discharged from the Intensive Care Unit and after 61 days he was discharged from our hospital to a rehabilitation center. At the time of discharge, serum LDH and serum creatinine had decreased to levels of 190 U/L and 1.18 mg/dL, respectively.

As knowledge on COVID-19 grows, studies are increasingly indicating that patients with COVID-19 are at risk of deep venous thrombosis and pulmonary embolisms 7, 8 . A recent case-report found multiple cerebral infarcts in three separate patients with COVID-19, suggesting that the risk for thrombotic events may not be limited to the venous system 9 We acknowledge that the kidney infarctions may not have been the sole cause of acute kidney injury in these patients. Direct cytopathic effects of SARS-CoV-2 on kidney tubular and endothelial cells due to kidney tropism have been suggested and were not excluded in our patients 13, 14 . Additionally, severely ill patients with COVID-19 may also be prone to other risk factors for acute kidney injury, including hemodynamic instability and drug toxicity.

However, both patients did not experience hemodynamic instability in the period prior to the development of acute kidney injury and the clear radiological evidence of kidney infarction makes it probable that the infarctions at least contributed to the loss of kidney function in both patients.

In conclusion, we demonstrated two cases of patients with COVID-19 who developed an acute decrease in kidney function and that had radiological signs of perfusion defects.

These data suggest that the differential diagnosis of acute kidney injury in COVID-19 patients should include kidney infarction, which may have important preventive and therapeutic implications.

Support: None. 2 eGFR was assessed using the CKD-EPI formula, based on serum creatinine. 3 Not measured on the day of kidney function deterioration, but 5 days later 4 Not measured on the day of kidney function deterioration, but 6 days earlier.

Note: Conversion factors for units: Hemoglobin in g/dL to mmol/L, x0.6206; lactate in mg/dL to mmol/L, x0.111; glucose in mg/dL to mmol/L, x0.0555; ionized calcium in mEq/L to mmol/L, x0.5; serum creatinine in mg/dL to μmol/L, x88.4; fibrinogen in mg/dL to μmol/L, x0.0294; urinary creatinine in mg/dL to μmol/L, x88.4.

Kidney impairment is associated with in-hospital death of COVID-19 patients

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, china

Caution on kidney dysfunctions of 2019-nCoV patients

Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection

Kidney involvement in COVID-19 and rationale for extracorporeal therapies

Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: A systematic review and meta-analysis

Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Coagulopathy and antiphospholipid antibodies in patients with covid-19

Acute renal embolism. forty-four cases of renal infarction in patients with atrial fibrillation

Hypertension, thrombosis, kidney failure, and diabetes: Is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence

The role of inflammation in venous thromboembolism

Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in china

Multiorgan and renal tropism of SARS-CoV-2 [epub ahead of print

Computed tomography image in axial (C) and coronal (D) direction in the portal venous phase of patient 2 indicating a wedge-shaped perfusion defect dorsolateral in the interpolar area of the left kidney (arrows). Besides, multiple smaller perfusion defects were visible in the upper and lower poles of both kidneys